European Medicines Agency recommends restricting Trobalt to last-line therapy in partial epilepsy

View source ↗

Summary

The EMA recommends restricting Trobalt (vigabatrin) to last-line therapy for partial epilepsy due to safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy

Drugs mentioned

• Trobalt (ezogabine)